Ciprofloxacin is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Uncomplicated UTI (ciprofloxacin XR and ciprofloxacin), complicated UTI (ciprofloxacin).
  • Post-exposure prophylaxis for inhalation anthrax. CDC recommends as first line agent + 1-2 additional agent(s) with in vitro activity (for inhalation anthrax, see "biodefense-anthrax" module).
  • Complicated intra-abdominal infections (in combination with metronidazole)
  • Infectious diarrhea
  • Endocervical and urethral infections caused N. gonorrhoeae (high resistance rates reported in Hawaii and California).
  • Empiric therapy for neutropenic fever (in combination with piperacillin); typhoid fever
  • Nosocomial pneumonia
  • Prostatitis
  • Acute sinusitis
  • Skin and soft tissue infections; bone and joint infections 11) bacterial conjunctivitis (ophthalmic ointment) 12) bacterial conjuctivitis and corneal ulcers (ophthalmic solution) 13) Acute otitis externa (otic suspension)

NON-FDA APPROVED USES

  • Tuberculosis, MAC and other atypical mycobacterial infections (2nd or 3rd line)

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: December 22, 2011